Cite
HARVARD Citation
Lingohr-Smith, M. et al. (n.d.). 558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety. Journal for immunotherapy of cancer. p. A337. [Online].